CLINICAL RESEARCH: POST-INFARCTION MYOCARDIAL PERFUSION IMAGING
A Multinational Study to Establish the Value of Early Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Identifying a Low-Risk Group for Early Hospital Discharge After Acute Myocardial Infarction
John J. Mahmarian, MD, FACC*,1,*,
Leslee J. Shaw, PhD ,2,
Neil G. Filipchuk, MD ,3,
Habib A. Dakik, MD ,
Sherif S. Iskander, MD||,4,
Terrence D. Ruddy, MD¶,
Milena J. Henzlova, MD#,4,
Felix Keng, MD**,
Adel Allam, MD,
Lemuel A. Moyé, MD, PhD,
Craig M. Pratt, MD, FACC* for the INSPIRE Investigators
* Methodist DeBakey Heart Center, Department of Cardiology, The Methodist Hospital, Houston, Texas
Cedars-Sinai Medical Center, Los Angeles, California
University of Calgary, Calgary, Alberta, Canada
American University of Beirut, Beirut, Lebanon
|| Cardiovascular Associates of East Texas, Tyler, Texas
¶ University of Ottawa Heart Institute, Ottawa, Ontario, Canada
# Mount Sinai Medical Center, New York, New York
** National Heart Centre, Singapore, Singapore
Al-Azhar University, Cairo, Egypt
University of Texas School of Public Health, Houston, Texas.
Manuscript received March 30, 2006;
revised manuscript received July 5, 2006,
accepted July 6, 2006.
* Reprint requests and correspondence: Dr. John J. Mahmarian, Department of Cardiology, Methodist DeBakey Heart Center, 6550 Fannin Street, SM-677, Houston, Texas 77030. (Email: jmahmarian{at}tmh.tmc.edu).
OBJECTIVES: The purpose of this study was to determine whether gated adenosine Tc-99m sestamibi single-photon emission computed tomography (ADSPECT) could accurately define risk and thereby guide therapeutic decision making in stable survivors of acute myocardial infarction (AMI).
BACKGROUND: Controversy continues as to the role of noninvasive stress imaging in stratifying risk early after AMI.
METHODS: The INSPIRE (Adenosine Sestamibi Post-Infarction Evaluation) trial is a prospective multicenter trial which enrolled 728 clinically stable survivors of AMI who had gated ADSPECT within 10 days of hospital admission and subsequent 1-year follow-up. Event rates were assessed within prospectively defined INSPIRE risk groups based on the adenosine-induced left ventricular perfusion defect size, extent of ischemia, and ejection fraction.
RESULTS: Total cardiac events/death and reinfarction significantly increased within each INSPIRE risk group from low (5.4%, 1.8%), to intermediate (14%, 9.2%), to high (18.6%, 11.6%) (p < 0.01). Event rates at 1 year were lowest in patients with the smallest perfusion defects but progressively increased when defect size exceeded 20% (p < 0.0001). The perfusion results significantly improved risk stratification beyond that provided by clinical and ejection fraction variables. The low-risk INSPIRE group, comprising one-third of all enrolled patients, had a shorter hospital stay with lower associated costs compared with the higher-risk groups (p < 0.001).
CONCLUSIONS: Gated ADSPECT performed early after AMI can accurately identify a sizeable low-risk group who have a <2% death and reinfarction rate at 1 year. Identifying these low-risk patients for early hospital discharge may improve utilization of health care resources at considerable cost savings.
|
Abbreviations and Acronyms
| | ADSPECT = adenosine technetium-99m sestamibi single-photon emission computed tomography | | ACS = acute coronary syndromes | | AMI = acute myocardial infarction | | ANOVA = analysis of variance | | CI = confidence interval | | CR = coronary revascularization | | ETT = exercise treadmill testing | | GLM = general linear modeling | | LVEF = left ventricular ejection fraction | | PDS = perfusion defect size | | RR = relative risk | | SDS = summed difference score | | SRS = summed rest score | | SSS = summed stress score | | TIMI = Thrombolysis In Myocardial Infarction |
|
Related Article
-
Noninvasive Risk Stratification After Myocardial Infarction: New Evidence, New Questions
- Raymond J. Gibbons and Todd D. Miller
J. Am. Coll. Cardiol. 2006 48: 2468-2470.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
F. A. Flachskampf, M. Schmid, C. Rost, S. Achenbach, A. N. DeMaria, and W. G. Daniel
Cardiac imaging after myocardial infarction
Eur. Heart J.,
February 1, 2011;
32(3):
272 - 283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Chua
The evolving role of molecular imaging for coronary artery disease: where do we stand today?
Heart Asia,
July 5, 2010;
1(1):
1 - 5.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Scirica
Acute Coronary Syndrome: Emerging Tools for Diagnosis and Risk Assessment
J. Am. Coll. Cardiol.,
April 6, 2010;
55(14):
1403 - 1415.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Chang, F. Nabi, J. Xu, L. E. Peterson, A. Achari, C. M. Pratt, and J. J. Mahmarian
The Coronary Artery Calcium Score and Stress Myocardial Perfusion Imaging Provide Independent and Complementary Prediction of Cardiac Risk
J. Am. Coll. Cardiol.,
November 10, 2009;
54(20):
1872 - 1882.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mahmarian, M. D. Cerqueira, A. E. Iskandrian, T. M. Bateman, G. S. Thomas, R. C. Hendel, L. A. Moye, and A. W. Olmsted
Regadenoson Induces Comparable Left Ventricular Perfusion Defects as Adenosine: A Quantitative Analysis From the ADVANCE MPI 2 Trial
J. Am. Coll. Cardiol. Img.,
August 1, 2009;
2(8):
959 - 968.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Botvinick
Current Methods of Pharmacologic Stress Testing and the Potential Advantages of New Agents
J. Nucl. Med. Technol.,
March 1, 2009;
37(1):
14 - 25.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Kwon, C. M. Halley, T. P. Carrigan, V. Zysek, Z. B. Popovic, R. Setser, P. Schoenhagen, R. C. Starling, S. D. Flamm, and M. Y. Desai
Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
J. Am. Coll. Cardiol. Img.,
January 1, 2009;
2(1):
34 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Dorfman, D. C. Sullivan, M. D. Schnall, L. M. Matrisian, and for the Translational Research Working Group
The Translational Research Working Group Developmental Pathway for Image-Based Assessment Modalities
Clin. Cancer Res.,
September 15, 2008;
14(18):
5678 - 5684.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Hayat and R. Senior
Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?
Eur. Heart J.,
February 1, 2008;
29(3):
299 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mahmarian
Computed Tomography Coronary Angiography as an Anatomic Basis for Risk Stratification: Deja Vu or Something New?
J. Am. Coll. Cardiol.,
September 18, 2007;
50(12):
1171 - 1173.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
988 - 1003.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mahmarian and C. M. Pratt
Reply
J. Am. Coll. Cardiol.,
June 5, 2007;
49(22):
2227 - 2228.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mahmarian, H. A. Dakik, N. G. Filipchuk, L. J. Shaw, S. S. Iskander, T. D. Ruddy, F. Keng, M. J. Henzlova, A. Allam, L. A. Moye, et al.
An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2458 - 2467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons and T. D. Miller
Noninvasive Risk Stratification After Myocardial Infarction: New Evidence, New Questions
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2468 - 2470.
[Full Text]
[PDF]
|
|
|
|
